Page 23

CELL THERAPY FOR CRITICAL LIMB ISCHEMIA Eric T. Choi, MD, is a vascular surgeon who performs endovascular interventions for diabetic patients with limb-threatening ischemia or infection. Preventing amputations is his goal. For patients not eligible for revascularization, Dr. Choi is researching novel nonsurgical therapies to stimulate vessel, bone, and tissue repair. In one Temple clinical trial, Dr. Choi offers patients autologous bone marrow therapy—basically extracting the patients’ own bone marrow cells and directly injecting these cells into the ischemic tissue to help increase circulation and increase amputation-free survival.

BENDING THE TECHNOLOGY TO FIT THE PATIENT Howard A. Cohen, MD, is an interventional cardiologist responsible for several advances in percutaneous coronary intervention. Of particular note: his pioneering efforts in radial (wrist) artery access for angioplasty and his participation in the development of cannulation of the TandemHeart™, a percutaneous left ventricular assist device that supports the heart during complex coronary interventions. His newest lines of research at Temple— including “hybrid” catheter-plus-minimally invasive surgical techniques, percutaneous partial left heart bypass, gene therapy, and percutaneous methods for valve repair and replacement—promise further gains in coronary care, especially for high-risk patients such as the elderly, those in cardiogenic shock or with acute MI, or those with comorbidities or complex coronary blockages.

HEART | LUNG

19

Profile for Temple Health

Temple University School of Medicine - Highlights of Basic and Clinical Research - 2014  

Temple University School of Medicine is pushing the boundaries of science to help reduce the devastating effects of heart and lung disease,...

Temple University School of Medicine - Highlights of Basic and Clinical Research - 2014  

Temple University School of Medicine is pushing the boundaries of science to help reduce the devastating effects of heart and lung disease,...